Comments on: FDA May Add Suicide Warnings To Epilepsy Meds

By: Just A Thought

Just A Thought — Fri, 06 Jun 2008 10:20:22 +0000

And incidentally, that these warnings only come about because the drugs are being used to treat things other than epilepsy, is insulting to epileptics.

By: Just A Thought

Just A Thought — Fri, 06 Jun 2008 09:50:36 +0000

I’m a little tired of the practice of slapping every possible warning on everything, to aid in the defense of drug companies, to lay the blame on the patient or the doctor.

They were warned in bold print on a packaging insert (says the pharma defense attorney).

Maybe the suicides are because the FDA won’t stand up for people that expect their protective body to protect them, creating hopelessness. It’s not news that MedWatch is an overwhelmed joke. But to do this means they are not planning to attempt a better process. I hope to God no one goes along with giving the FDA more money.

Nice win pharma!

By: Sam

Sam — Thu, 05 Jun 2008 20:15:34 +0000

Once again the FDA fails the American public in its evaluation drugs

By: Anne

Anne — Wed, 04 Jun 2008 17:21:10 +0000

My daughter was placed by her psychiatrist on Lamictal (Glaxo) for bipolar depression, an “approved use”. Very soon after starting the drug, she became suicidal - most pronounced before and during her monthly cycle. Very hormonal reaction. Finally tapering off the medication after close calls, she had to be hospitalized because each taper exacerbated these symptoms.

We told Medwatch in great detail and were advised to do the same with Glaxo, which we did. I have seen concern about this suicidality on several blogs and websites, but nothing from doctors or the company.

I hope for once the FDA will do the right thing and require prominent warnings on this whole class of drugs in a timely fashion. Months of worry, and close oversight, and luck saved her life.

By: DV Jr

DV Jr — Wed, 04 Jun 2008 16:29:16 +0000

“Champix”?